• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 从无症状患者中排出:潜在肺外组织储库的贡献。

SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs.

机构信息

1Southern Research, Frederick, Maryland.

2College of Optometry, Western University of Health Sciences, Pomona, California.

出版信息

Am J Trop Med Hyg. 2020 Jul;103(1):18-21. doi: 10.4269/ajtmh.20-0279. Epub 2020 May 13.

DOI:10.4269/ajtmh.20-0279
PMID:32406369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7356473/
Abstract

The ongoing pandemic COVID-19, caused by SARS-CoV-2, has already resulted in more than 3 million cases and more than 200,000 deaths globally. Significant clinical presentations of COVID-19 include respiratory symptoms and pneumonia. In a minority of patients, extrapulmonary organs (central nervous system, eyes, heart, and gut) are affected, with detection of viral RNA in bodily secretions (stool, tears, and saliva). Infection of such extrapulmonary organs may serve as a reservoir for SARS-CoV-2, representing a potential source of viral shedding after the cessation of respiratory symptoms in recovered patients or in asymptomatic individuals. It is extremely important to understand this phenomenon, as individuals with intermittent virus shedding could be falsely identified as reinfected and may benefit from ongoing antiviral treatment. The potential of SARS-CoV-2 infection to rapidly disseminate and infect extrapulmonary organs is likely mediated through the nonstructural and accessory proteins of SARS-CoV-2, which act as ligands for host cells, and through evasion of host immune responses. The focus of this perspective is the extrapulmonary tissues affected by SARS-CoV-2 and the potential implications of their involvement for disease pathogenesis and the development of medical countermeasures.

摘要

由 SARS-CoV-2 引起的持续大流行 COVID-19 已在全球范围内导致超过 300 万例病例和超过 20 万例死亡。COVID-19 的显著临床特征包括呼吸道症状和肺炎。在少数患者中,肺外器官(中枢神经系统、眼睛、心脏和肠道)受到影响,身体分泌物(粪便、眼泪和唾液)中检测到病毒 RNA。这些肺外器官的感染可能成为 SARS-CoV-2 的储库,代表了在呼吸道症状停止后康复患者或无症状个体中病毒脱落的潜在来源。了解这种现象极其重要,因为间歇性病毒脱落的个体可能被错误地认定为再次感染,并可能受益于持续的抗病毒治疗。SARS-CoV-2 通过其非结构和辅助蛋白,作为宿主细胞的配体,以及通过逃避宿主免疫反应,迅速传播和感染肺外器官的潜力。本观点的重点是受 SARS-CoV-2 影响的肺外组织,以及它们参与疾病发病机制和医疗对策发展的潜在意义。

相似文献

1
SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs.SARS-CoV-2 从无症状患者中排出:潜在肺外组织储库的贡献。
Am J Trop Med Hyg. 2020 Jul;103(1):18-21. doi: 10.4269/ajtmh.20-0279. Epub 2020 May 13.
2
Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.儿童 SARS-CoV-2 呼吸道和胃肠道病毒脱落持续时间:系统评价和数据综合。
Pediatr Infect Dis J. 2020 Sep;39(9):e249-e256. doi: 10.1097/INF.0000000000002814.
3
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.无症状和轻度症状 SARS-CoV-2 感染患者的病毒脱落动力学。
Clin Microbiol Infect. 2020 Nov;26(11):1556.e1-1556.e6. doi: 10.1016/j.cmi.2020.07.008. Epub 2020 Jul 9.
4
SARS-CoV-2: The viral shedding vs infectivity dilemma.严重急性呼吸综合征冠状病毒2:病毒脱落与传染性的困境。
Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20.
5
Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.SARS-CoV-2 的眼部症状:可能存在眼部传播或病毒脱落的迹象。
Ocul Immunol Inflamm. 2020 Nov 16;28(8):1269-1279. doi: 10.1080/09273948.2020.1799035. Epub 2020 Sep 1.
6
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.2019 年冠状病毒病患者的胃肠道症状和粪便病毒脱落的流行情况:系统评价和荟萃分析。
JAMA Netw Open. 2020 Jun 1;3(6):e2011335. doi: 10.1001/jamanetworkopen.2020.11335.
7
Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2.COVID-19 对胃肠道的影响和 SARS-CoV-2 的潜在粪便传播。
J Zhejiang Univ Sci B. 2020;21(9):749-751. doi: 10.1631/jzus.B2000253.
8
Prolonged Fecal Shedding of SARS-CoV-2 in Pediatric Patients: A Quantitative Evidence Synthesis.儿科患者中 SARS-CoV-2 的粪便长时间排出:定量证据综合。
J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):150-152. doi: 10.1097/MPG.0000000000002798.
9
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
10
SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts.SARS-CoV-2 感染非洲绿猴可导致轻度呼吸道疾病,通过 PET/CT 成像可识别,且可从呼吸道和胃肠道排出具有感染性的病毒。
PLoS Pathog. 2020 Sep 18;16(9):e1008903. doi: 10.1371/journal.ppat.1008903. eCollection 2020 Sep.

引用本文的文献

1
Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants.新冠后状况与神经炎症:抗氧化剂的潜在治疗方法
Antioxidants (Basel). 2025 Jul 8;14(7):840. doi: 10.3390/antiox14070840.
2
Vaxtherapy, a Multiphase Therapeutic Protocol Approach for Longvax, the COVID-19 Vaccine-Induced Disease: Spike Persistence as the Core Culprit and Its Downstream Effects.疫苗疗法,一种针对新冠疫苗诱导疾病Longvax的多阶段治疗方案:刺突蛋白持续存在作为核心罪魁祸首及其下游影响
Diseases. 2025 Jun 30;13(7):204. doi: 10.3390/diseases13070204.
3
Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long COVID.了解新型冠状病毒感染后的自身免疫反应以及长期新冠的发病机制。
Med Rev (2021). 2024 May 27;4(5):367-383. doi: 10.1515/mr-2024-0013. eCollection 2024 Oct.
4
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.新型冠状病毒肺炎血栓形成:区分病理、机制、表型特征及管理
J Thromb Thrombolysis. 2025 Jan;58(1):15-49. doi: 10.1007/s11239-024-03028-4. Epub 2024 Aug 23.
5
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review).大流行期间的一个午夜之梦:褪黑素,从抗炎先兆到急性和长新冠 COVID-19 中的线粒体救星(综述)。
Int J Mol Med. 2024 Mar;53(3). doi: 10.3892/ijmm.2024.5352. Epub 2024 Feb 1.
6
Neurological Involvements in COVID-19: A hospital-based study.新型冠状病毒肺炎的神经系统受累:一项基于医院的研究。
Iran J Child Neurol. 2023 Summer;17(3):69-80. doi: 10.22037/ijcn.v17i2.36829. Epub 2023 Jul 1.
7
Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection.一名儿科患者急性感染3个月后,肠道上皮中持续存在严重急性呼吸综合征冠状病毒2核衣壳蛋白
JPGN Rep. 2021 Dec 3;3(1):e152. doi: 10.1097/PG9.0000000000000152. eCollection 2022 Feb.
8
Epidemiologic Assessment of Pediatric Inflammatory Bowel Disease Presentation in NYC During COVID-19.在 COVID-19 大流行期间纽约儿科炎症性肠病表现的流行病学评估。
J Pediatr Gastroenterol Nutr. 2023 May 1;76(5):622-626. doi: 10.1097/MPG.0000000000003740. Epub 2023 Feb 19.
9
SARS-CoV-2 versus other minor viral infection on kidney injury in asymptomatic and mildly symptomatic patients.新型冠状病毒与其他轻微病毒感染对无症状和轻度症状患者肾脏损伤的影响。
Virulence. 2022 Dec;13(1):1349-1357. doi: 10.1080/21505594.2022.2107602.
10
Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.褪黑素:调节 COVID-19 后急性后遗症中的病毒相分离和表观转录组学。
Int J Mol Sci. 2022 Jul 23;23(15):8122. doi: 10.3390/ijms23158122.

本文引用的文献

1
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
2
Case Report: Viral Shedding for 60 Days in a Woman with COVID-19.病例报告:一名 COVID-19 女性患者病毒脱落 60 天。
Am J Trop Med Hyg. 2020 Jun;102(6):1210-1213. doi: 10.4269/ajtmh.20-0275.
3
The evidence of SARS-CoV-2 infection on ocular surface.SARS-CoV-2 感染眼表的证据。
Ocul Surf. 2020 Jul;18(3):360-362. doi: 10.1016/j.jtos.2020.03.010. Epub 2020 Apr 11.
4
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.首例与 SARS-CoV-2 相关的脑膜炎/脑炎。
Int J Infect Dis. 2020 May;94:55-58. doi: 10.1016/j.ijid.2020.03.062. Epub 2020 Apr 3.
5
SARS-CoV-2 in wastewater: potential health risk, but also data source.废水中的新型冠状病毒:潜在健康风险,但也是数据来源。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):533-534. doi: 10.1016/S2468-1253(20)30087-X. Epub 2020 Apr 1.
6
Nervous system involvement after infection with COVID-19 and other coronaviruses.感染 COVID-19 和其他冠状病毒后的神经系统并发症。
Brain Behav Immun. 2020 Jul;87:18-22. doi: 10.1016/j.bbi.2020.03.031. Epub 2020 Mar 30.
7
Follow-up of asymptomatic patients with SARS-CoV-2 infection.新型冠状病毒2019感染无症状患者的随访
Clin Microbiol Infect. 2020 Jul;26(7):957-959. doi: 10.1016/j.cmi.2020.03.024. Epub 2020 Mar 28.
8
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.中国湖北省 2019 年冠状病毒病(COVID-19)患者的眼部表现特征。
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.
9
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.113 例新冠肺炎死亡患者的临床特征:回顾性研究。
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
10
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.模拟新型冠状病毒肺炎(COVID-19)在金黄地鼠模型中的临床和病理表现:对疾病发病机制和传染性的影响。
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446. doi: 10.1093/cid/ciaa325.